Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Rehn

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Scientific Reports|September 12, 2025
Artifact detection in fluorescence microscopy using convolutional autoencoderFabian Rehn, Marlene Pils, Tuyen Bujnicki, et al.
Scientific Reports|August 22, 2024
IAPP - oligomerisation levels in plasma of people with type 2 diabetesFabian Rehn, Victoria Kraemer-Schulien, Tuyen Bujnicki, et al.
Diagnostics (Basel, Switzerland)|May 27, 2023
Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer's DiseaseMarlene Pils, Alexandra Dybala, Fabian Rehn, et al.
Alzheimer'S Research & Therapy|October 14, 2024
Elevated Aβ aggregates in feces from Alzheimer's disease patients: a proof-of-concept studyMarlene Pils, Alexandra Dybala, Anja Schaffrath, et al.
NPJ Parkinson'S Disease|June 2, 2022
Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle countingLara Blömeke, Marlene Pils, Victoria Kraemer-Schulien, et al.
Communications Medicine|December 10, 2024
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjectsLara Blömeke, Fabian Rehn, Marlene Pils, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 26, 2024
Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathologyLara Blömeke, Fabian Rehn, Victoria Kraemer-Schulien, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Scientific Reports|September 12, 2025
Artifact detection in fluorescence microscopy using convolutional autoencoderFabian Rehn, Marlene Pils, Tuyen Bujnicki, et al.
Scientific Reports|August 22, 2024
IAPP - oligomerisation levels in plasma of people with type 2 diabetesFabian Rehn, Victoria Kraemer-Schulien, Tuyen Bujnicki, et al.
Diagnostics (Basel, Switzerland)|May 27, 2023
Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer's DiseaseMarlene Pils, Alexandra Dybala, Fabian Rehn, et al.
Alzheimer'S Research & Therapy|October 14, 2024
Elevated Aβ aggregates in feces from Alzheimer's disease patients: a proof-of-concept studyMarlene Pils, Alexandra Dybala, Anja Schaffrath, et al.
NPJ Parkinson'S Disease|June 2, 2022
Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle countingLara Blömeke, Marlene Pils, Victoria Kraemer-Schulien, et al.
Communications Medicine|December 10, 2024
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjectsLara Blömeke, Fabian Rehn, Marlene Pils, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 26, 2024
Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathologyLara Blömeke, Fabian Rehn, Victoria Kraemer-Schulien, et al.
Pageof 1